COR vs SOLV: fair value comparison
Cencora, Inc. and Solventum Corporation · Updated 2026-09-12
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, COR currently sits closer to the top of our discount ranking.
| COR | SOLV | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $321.57 | $87.45 |
| 12-month range | $264.69–$372.65 | $64.35–$90.95 |
| Sector rank | #76 of 113 Healthcare | #81 of 113 Healthcare |
| Quality grade | F | F |
| Leverage | High | Moderate |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| DCF cross-check | Undervalued | — |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: COR fair value analysis · SOLV fair value analysis